Dr. Noto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Catamore Blvd
East Providence, RI 02914Phone+1 401-432-2520Fax+1 401-432-2457
Education & Training
- University of Pennsylvania Health SystemResidency, Nuclear Medicine, 1986 - 1988
- NYU Grossman School of MedicineResidency, Radiology-Diagnostic, 1983 - 1986
- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1982 - 1983
- University of Rochester School of Medicine and DentistryClass of 1982
Certifications & Licensure
- MA State Medical License 2000 - 2025
- RI State Medical License 1988 - 2024
- NY State Medical License 1983 - 2002
- PA State Medical License 1986 - 1988
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Clinical Trials
- A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma Start of enrollment: 2009 Jun 04
Publications & Presentations
PubMed
- Fibrin-Positron Emission Tomography Imaging Reveals Ongoing Lung Injury in Idiopathic Pulmonary Fibrosis.Julia K Munchel, Abhinav K Misra, Scott A Collins, Ryan DiGregorio, Amy Palmisciano
American Journal of Respiratory and Critical Care Medicine. 2024-08-15 - 5 citationsBiomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.Camilo Jimenez, Bennett B Chin, Richard B Noto, Joseph S Dillon, Lilja Solnes
Endocrine-Related Cancer. 2023-02-01 - 1 citationsDiversity, not Divisiveness, is the Future of Nuclear MedicineRichard B. Noto
Journal of Nuclear Medicine. 2020-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: